News

In Vivo StudiWell-designed animal studies require more than selecting an appropriate disease model. Experimental grouping, endpoint selection, procedural consistency, and quality control all directly affect data variability, reproducibility, and the strength of the resulting evidence. In this Q&A, Toprion’s preclinical research team discusses several common challenges in animal study design and explains how standardized workflows […]

Bringing a small molecule from discovery to clinical development is a complex process that requires far more than identifying a biologically active compound. Despite promising early-stage data, many development programs fail before or shortly after entering clinical trials due to insufficient efficacy, unexpected safety findings, or inadequate translational evidence. For many programs, these challenges do

Hyperthyroid heart disease (HHD) represents one of the most severe cardiovascular complications of thyroid hormone excess. Clinically, it is characterized by persistent tachycardia, cardiac hypertrophy, arrhythmia susceptibility, and progressive structural remodeling. Despite its well-defined clinical phenotype, preclinical modeling of HHD remains challenging due to variability in disease induction, incomplete recapitulation of human pathology, and limitations

For decades, preclinical research has relied heavily on two experimental systems: traditional cell cultures and animal models. Both have contributed significantly to our understanding of disease biology and therapeutic development. Yet both present well-recognized limitations. Conventional two-dimensional cell cultures are often unable to reproduce the structural complexity, cellular diversity, and microenvironmental interactions found in human

For decades, drug discovery has largely relied on inhibition. Whether targeting kinases, receptors, or enzymes, most therapeutic strategies have focused on blocking protein activity. However, many disease-driving proteins remain difficult―or even impossible―to inhibit directly. The emergence of targeted protein degradation technologies, particularly PROTACs, has introduced a fundamentally different approach: instead of blocking proteins, researchers can

Hyperuricemia (HUA) research has expanded far beyond gout alone. Elevated uric acid levels are now closely associated with chronic kidney disease, metabolic dysfunction, cardiovascular complications, and systemic inflammation. As interest in urate-lowering therapeutics and metabolic disease research continues to grow, establishing stable and translationally relevant animal models has become increasingly important in preclinical studies. However,

Lung metastasis is one of the most common progression patterns observed across solid tumors including breast cancer, melanoma, colorectal cancer, and renal carcinoma. Because metastatic dissemination involves multiple biological stages ― from circulation survival to lung colonization and outgrowth ― appropriate model selection is critical for generating reproducible and translationally meaningful data. Unlike in vitro

Overview Flow cytometry is widely used in preclinical research for multi-parameter cellular analysis, including immune profiling, cell cycle analysis, and biomarker quantification. However, similar to other high-throughput assays, data reliability depends heavily on experimental design, sample quality, and analytical consistency. At Toprion, we focus on delivering robust, reproducible, and decision-ready flow cytometry data across different

Overview ELISA is widely used for quantitative detection in preclinical and biomedical research. However, data reliability often depends less on the method itself, and more on execution quality and control systems. At Toprion, we focus on delivering consistent and decision-ready ELISA data through standardized workflows and quality control. What Determines ELISA Data Quality While ELISA

Understanding protein–DNA interactions is fundamental to studying gene regulation, epigenetic modifications, and transcriptional control. Traditional methods such as ChIP-seq have long been used for this purpose, but they often face limitations in sensitivity, efficiency, and sample
requirements.